- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
Trade-Ideas LLC identified C.R. Bard (BCR) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate